We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPI and vascular endothelial cell injury. Plasma TF (273 ยฑ 90 pg/ml) and TFPI (252 ยฑ 125 ng/ml) levels wer
Homocysteine and tissue factor pathway inhibitor levels in patients with Fabry's disease
โ Scribed by S. FEDI; F. GENSINI; A. M. GORI; R. ABBATE; W. BORSINI
- Book ID
- 109149114
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 123 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1538-7933
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPl and vascular endothelial cell injury. Plasma TF (273 2 90 pg/ml) and TFPl (252 2 125 nglml) levels wer
We examined hemostatic abnormalities in 23 patients with acute myocardial infarction (AMI), 10 with pulmonary embolism (PE), and 10 with deep vein thrombosis (DVT). At the onset of AMI, plasma levels of tissue-type plasminogen activator (t-PA), PA inhibitor-I (PAI-I), fibrin-D-dimer, thrombin-antith
Plasma levels of tissue factor pathway inhibitor (TFPI)-activated factor Xa (FXa) complex were measured in patients with disseminated intravascular coagulation (DIC), pre-DIC, and DIC. Plasma levels of plasmin-plasmin inhibitor complex (PPIC), D-dimer, and soluble fibrin monomer (SFM) were significa